Exciva Initiates Phase 2/3 SERENADA Trial For Alzheimer`s
29 Apr 2026 //
INDPHARMAPOST
Exciva Begins Dosing in Deraphan Trial for Alzheimer`s Agitation
28 Apr 2026 //
PHARMIWEB
EQT Life Sciences Co-Leads EUR 51M Investment In Exciva
20 Jan 2026 //
PR NEWSWIRE

Market Place
Sourcing Support